Acute Pancreatitis Global Market Report 2024: Market to Surge to $7.41 Billion by 2028, Driven by Technological Advances and Growing Health Concerns - Long-term Forecast to 2033
25 janv. 2024 09h14 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acute Pancreatitis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest acute pancreatitis market...
First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference
15 mai 2023 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis
11 mai 2023 07h00 HE
|
First Wave BioPharma, Inc.
Top line data read-out on track for July 2023 BOCA RATON, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (NASDAQ: FWBI), a...
Ariel Precision Medicine Expands Executive Team with Appointment of Dr. David C. Whitcomb as Chief Scientific Officer
23 août 2021 11h20 HE
|
Ariel Precision Medicine
Pittsburgh, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held biotechnology company developing innovative solutions for complex chronic disease, announced the...
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein
24 nov. 2020 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis
15 juin 2020 08h00 HE
|
Ariel Precision Medicine
New York; Chapel Hill, NC; Pittsburgh, June 15, 2020 (GLOBE NEWSWIRE) -- Mission Cure Holdings, LLC, Path BioAnalytics, Inc. and Ariel Precision Medicine, Inc. jointly announced the creation of a...
Ariel Precision Medicine Named Life Sciences PA Emerging Company of the Year
19 mars 2019 08h00 HE
|
Ariel Precision Medicine
Pittsburgh, March 19, 2019 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held, clinically integrated, genomics and health technology company developing innovative solutions for...
Ariel Precision Medicine Inc. Launches New Genomic Tools for Early Diagnosis, Personalized Management of Pancreatic Diseases
24 sept. 2018 12h10 HE
|
Ariel Precision Medicine
Pittsburgh, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held integrated genomics and digital health company developing innovative solutions for complex chronic...